Published in Am J Public Health on August 08, 2013
From genomes to societies: a holistic view of determinants of human health. Curr Opin Biotechnol (2014) 0.75
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 58.92
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (2003) 28.61
Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet (2009) 12.07
Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol (1977) 9.89
Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry (2000) 9.02
Physical and mental health effects of intimate partner violence for men and women. Am J Prev Med (2002) 8.32
Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry (2010) 8.02
Cross-national epidemiology of major depression and bipolar disorder. JAMA (1996) 7.98
The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry (2011) 6.66
Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord (1994) 6.61
A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34
The effects of stressful life events on depression. Annu Rev Psychol (1997) 5.98
Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry (2008) 4.65
Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet (2005) 4.21
Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry (2006) 3.97
Current research trends in early life stress and depression: review of human studies on sensitive periods, gene-environment interactions, and epigenetics. Exp Neurol (2011) 2.20
Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. Am J Psychiatry (2008) 2.19
Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psychiatry (2007) 2.11
Most reported genetic associations with general intelligence are probably false positives. Psychol Sci (2012) 2.10
The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron (2011) 2.02
Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension. Arch Gen Psychiatry (2009) 2.01
Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry (2007) 1.93
Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population. Psychol Med (2009) 1.84
Evidence for prospective associations among depression and obesity in population-based studies. Obes Rev (2011) 1.78
Machine learning in genome-wide association studies. Genet Epidemiol (2009) 1.68
Probabilistic computer model developed from clinical data in national mammography database format to classify mammographic findings. Radiology (2009) 1.65
Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.56
The BDNF Val(66)Met x 5-HTTLPR x child adversity interaction and depressive symptoms: An attempt at replication. Am J Med Genet B Neuropsychiatr Genet (2008) 1.55
Does a higher educational level protect against anxiety and depression? The HUNT study. Soc Sci Med (2008) 1.55
New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotype. Biol Psychiatry (2008) 1.52
The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol Aging (2005) 1.49
Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms. Am J Med Genet B Neuropsychiatr Genet (2010) 1.42
Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms. Clin Cancer Res (2004) 1.33
Oxytocin receptor gene polymorphism (rs2254298) interacts with familial risk for psychopathology to predict symptoms of depression and anxiety in adolescent girls. Psychoneuroendocrinology (2010) 1.24
Identifying genetic interactions in genome-wide data using Bayesian networks. Genet Epidemiol (2010) 1.22
Depression Case Control (DeCC) Study fails to support involvement of the muscarinic acetylcholine receptor M2 (CHRM2) gene in recurrent major depressive disorder. Hum Mol Genet (2009) 1.18
A comparison of classification methods for predicting Chronic Fatigue Syndrome based on genetic data. J Transl Med (2009) 1.18
Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with major depression in women. Am J Med Genet (2002) 1.12
Evidence for HTR1A and LHPP as interacting genetic risk factors in major depression. Mol Psychiatry (2008) 1.04
FKBP5 and resistant attachment predict cortisol reactivity in infants: gene-environment interaction. Psychoneuroendocrinology (2010) 1.04
Allelic differences in the brain-derived neurotrophic factor Val66Met polymorphism in late-life depression. Am J Geriatr Psychiatry (2007) 1.02
Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett (2001) 1.01
Cortisol responses to emotional stress in men: association with a functional polymorphism in the 5HTR2C gene. Biol Psychol (2011) 0.98
The functional Val158Met polymorphism in catechol-O-methyltransferase (COMT) is associated with depression and motivation in men from a Swedish population-based study. J Affect Disord (2010) 0.98
Early life stress combined with serotonin 3A receptor and brain-derived neurotrophic factor valine 66 to methionine genotypes impacts emotional brain and arousal correlates of risk for depression. Biol Psychiatry (2010) 0.98
5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. Neuroreport (2009) 0.97
Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder. Int Clin Psychopharmacol (2011) 0.97
Glucocorticoid receptor gene polymorphisms and childhood adversity are associated with depression: New evidence for a gene-environment interaction. Am J Med Genet B Neuropsychiatr Genet (2009) 0.97
Personality and health care decision-making style. J Gerontol B Psychol Sci Soc Sci (2007) 0.97
Childhood maltreatment, the corticotropin-releasing hormone receptor gene and adult depression in the general population. Am J Med Genet B Neuropsychiatr Genet (2010) 0.97
Gene-gene interactions of the brain-derived neurotrophic-factor and neurotrophic tyrosine kinase receptor 2 genes in geriatric depression. Rejuvenation Res (2009) 0.95
Serotonin transporter gene, depressive symptoms, and interleukin-6. Circ Cardiovasc Genet (2009) 0.93
Association study of candidate variants of COMT with neuroticism, anxiety and depression. Am J Med Genet B Neuropsychiatr Genet (2008) 0.93
The dopamine D2 receptor gene and depressive and anxious symptoms in childhood: associations and evidence for gene-environment correlation and gene-environment interaction. Psychiatr Genet (2010) 0.93
Association of variants in innate immune genes with asthma and eczema. Pediatr Allergy Immunol (2011) 0.93
Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis. J Hum Genet (2009) 0.92
Evidence for epistasis between SLC6A4 and a chromosome 4 gene as risk factors in major depression. Am J Med Genet B Neuropsychiatr Genet (2010) 0.89
Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders: a 22-year longitudinal gene-environment study. Mol Psychiatry (2009) 0.89
Genetic association of the interaction between the BDNF and GSK3B genes and major depressive disorder in a Chinese population. J Neural Transm (Vienna) (2009) 0.88
Genetic variants in the DRD2 gene moderate the relationship between stressful life events and depressive symptoms in adults: cardiovascular risk in young Finns study. Psychosom Med (2007) 0.86
Impact of physical abuse on adulthood depressive symptoms among women. Issues Ment Health Nurs (2008) 0.86
Interaction of chronic stress with serotonin transporter and catechol-O-methyltransferase polymorphisms in predicting youth depression. Depress Anxiety (2010) 0.84
Personality traits are associated with acute major depression across the age spectrum. Aging Ment Health (2011) 0.84
Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy. Neurosci Lett (2008) 0.83
The gender gap in depression reconsidered: the influence of marital and employment status on the female/male ratio of treated incidence rates. Soc Psychiatry Psychiatr Epidemiol (2000) 0.82
Resolving the relationship between ApolipoproteinE and depression. Neurosci Lett (2009) 0.79
Multigene interactions and the prediction of depression in the Wisconsin Longitudinal Study. BMJ Open (2012) 0.79
Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder. Psychiatry Res (2010) 0.78
Genetics of unipolar major depressive disorder. Isr J Psychiatry Relat Sci (2010) 0.77
Proposed multigenic Composite Inheritance in major depression. Med Hypotheses (2005) 0.77
Do birth cohorts matter? Age-period-cohort analyses of the obesity epidemic in the United States. Soc Sci Med (2009) 3.87
Mechanism of actin network attachment to moving membranes: barbed end capture by N-WASP WH2 domains. Cell (2007) 3.04
Continuity and change in the social stratification of aging and health over the life course: evidence from a nationally representative longitudinal study from 1986 to 2001/2002 (Americans' Changing Lives Study). J Gerontol B Psychol Sci Soc Sci (2005) 2.87
Most reported genetic associations with general intelligence are probably false positives. Psychol Sci (2012) 2.10
Small-molecule regulation of zebrafish gene expression. Nat Chem Biol (2007) 2.00
Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence. Biochemistry (2003) 1.89
The Promises and Pitfalls of Genoeconomics* Annu Rev Econom (2012) 1.66
Probabilistic computer model developed from clinical data in national mammography database format to classify mammographic findings. Radiology (2009) 1.65
Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic Biol Med (2002) 1.34
Using anchoring vignettes to assess group differences in general self-rated health. J Health Soc Behav (2011) 1.33
Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production. J Biol Chem (2002) 1.29
Income, education, and inflammation: differential associations in a national probability sample (The MIDUS study). Psychosom Med (2010) 1.28
Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochim Biophys Acta (2006) 1.26
Peroxisomal proliferator-activated receptor alpha deficiency diminishes insulin-responsiveness of gluconeogenic/glycolytic/pentose gene expression and substrate cycle flux. Endocrinology (2003) 1.25
Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides. J Biol Inorg Chem (2004) 1.21
Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition. J Biol Chem (2004) 1.21
Age-related changes in drinking patterns from mid- to older age: results from the Wisconsin longitudinal study. Alcohol Clin Exp Res (2010) 1.18
Predicting adult health and mortality from adolescent facial characteristics in yearbook photographs. Demography (2009) 1.18
Living and dying for sex. A theory of aging based on the modulation of cell cycle signaling by reproductive hormones. Gerontology (2004) 1.13
Have we put an end to social promotion? Changes in school progress among children aged 6 to 17 from 1972 to 2005. Demography (2008) 1.12
Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease. J Alzheimers Dis (2008) 1.11
Determination of a glucose-dependent futile recycling rate constant from an intraperitoneal glucose tolerance test. Anal Biochem (2003) 1.07
The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications. CNS Drugs (2002) 1.07
Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression. J Neurochem (2004) 1.06
Do Older Adults Know Their Spouses' End-of-Life Treatment Preferences? Res Aging (2009) 1.06
Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases. Eur J Pharm Biopharm (2005) 1.05
fMRI activation during episodic encoding and metacognitive appraisal across the lifespan: risk factors for Alzheimer's disease. Neuropsychologia (2007) 1.02
The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught? Pharmacol Res (2004) 1.02
Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease. Free Radic Res (2009) 1.00
Benefits of educational attainment on adult fluid cognition: international evidence from three birth cohorts. Int J Epidemiol (2012) 1.00
Later-life Employment Preferences and Outcomes: The Role of Mid-life Work Experiences. Res Aging (2010) 0.99
Iron: a pathological mediator of Alzheimer disease? Dev Neurosci (2002) 0.98
Predictors of family conflict at the end of life: the experience of spouses and adult children of persons with lung cancer. Gerontologist (2009) 0.97
Explaining the gender wealth gap. Demography (2013) 0.97
Differential processing of amyloid-beta precursor protein directs human embryonic stem cell proliferation and differentiation into neuronal precursor cells. J Biol Chem (2009) 0.96
Neuroprotective properties of Bcl-w in Alzheimer disease. J Neurochem (2004) 0.96
Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain. Curr Alzheimer Res (2007) 0.95
Leuprolide acetate: a drug of diverse clinical applications. Expert Opin Investig Drugs (2007) 0.94
Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology. J Neurosci Res (2002) 0.93
Estrogen bows to a new master: the role of gonadotropins in Alzheimer pathogenesis. Ann N Y Acad Sci (2005) 0.92
A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women. Age Ageing (2008) 0.92
The gonadotropin connection in Alzheimer's disease. Endocrine (2005) 0.91
Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? Neurochem Int (2002) 0.91
Predicting the failure of amyloid-beta vaccine. Lancet (2002) 0.91
Identification of a gonadotropin-releasing hormone receptor orthologue in Caenorhabditis elegans. BMC Evol Biol (2006) 0.90
Reproductive hormones regulate the selective permeability of the blood-brain barrier. Biochim Biophys Acta (2008) 0.90
Evaluation of multiple models to distinguish closely related forms of disease using DNA microarray data: an application to multiple myeloma. Stat Appl Genet Mol Biol (2004) 0.89
The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease. Peptides (2002) 0.89
Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants. Free Radic Biol Med (2003) 0.89
Does Psychological Well-Being Change with Age?: Longitudinal Tests of Age Variations and Further Exploration of the Multidimensionality of Ryff's Model of Psychological Well-Being. Soc Sci Res (2011) 0.88
Steroidogenic acute regulatory protein (StAR): evidence of gonadotropin-induced steroidogenesis in Alzheimer disease. Mol Neurodegener (2006) 0.87
Luteinizing hormone receptor mediates neuronal pregnenolone production via up-regulation of steroidogenic acute regulatory protein expression. J Neurochem (2007) 0.87
Gonadotropins and cognition in older women. J Alzheimers Dis (2008) 0.87
The pregnancy hormones human chorionic gonadotropin and progesterone induce human embryonic stem cell proliferation and differentiation into neuroectodermal rosettes. Stem Cell Res Ther (2010) 0.87
Adventiously-bound redox active iron and copper are at the center of oxidative damage in Alzheimer disease. Biometals (2003) 0.87
Amyloid-beta precursor protein expression and modulation in human embryonic stem cells: a novel role for human chorionic gonadotropin. Biochem Biophys Res Commun (2007) 0.86
The cell cycle and hormonal fluxes in Alzheimer disease: a novel therapeutic target. Curr Pharm Des (2006) 0.86
Amyloid-beta: a (life) preserver for the brain. Neurobiol Aging (2002) 0.85
Prion disease diagnosis by proteomic profiling. J Proteome Res (2009) 0.84
Complicated grief symptoms in caregivers of persons with lung cancer: the role of family conflict, intrapsychic strains, and hospice utilization. Omega (Westport) (2011) 0.84
Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studies. J Biol Chem (2008) 0.84
Redox active iron accumulation in aceruloplasminemia. Neuropathology (2008) 0.84
Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression. J Endocrinol (2006) 0.84
Gender differences in Alzheimer disease: the role of luteinizing hormone in disease pathogenesis. Alzheimer Dis Assoc Disord (2005) 0.83
Hypothalamic-pituitary-gonadal axis homeostasis predicts longevity. Age (Dordr) (2011) 0.83
Opioid and progesterone signaling is obligatory for early human embryogenesis. Stem Cells Dev (2009) 0.82
Copper Induces Apoptosis of Neuroblastoma Cells Via Post-translational Regulation of the Expression of Bcl-2-family Proteins and the tx Mouse is a Better Model of Hepatic than Brain Cu Toxicity. Int J Clin Exp Med (2008) 0.82
A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele. BMC Med Genet (2008) 0.82
Amyloid-beta: phylogenesis of a chameleon. Brain Res Brain Res Rev (2004) 0.82
Is TNF a link between aging-related reproductive endocrine dyscrasia and Alzheimer's disease? J Alzheimers Dis (2011) 0.81
Activin receptor signaling regulates prostatic epithelial cell adhesion and viability. Neoplasia (2009) 0.81
Precarious employment, bad jobs, labor unions, and early retirement. J Gerontol B Psychol Sci Soc Sci (2011) 0.80
Causes and Consequences of Cognitive Functioning Across the Life Course. Educ Res (2010) 0.80
Involvement of Maillard reactions in Alzheimer disease. Neurotox Res (2002) 0.80
Iron homeostasis is maintained in the brain, but not the liver, following mild hypoxia. Redox Rep (2007) 0.80
Gonadotropins and Alzheimer's disease: the link between estrogen replacement therapy and neuroprotection. Acta Neurobiol Exp (Wars) (2004) 0.79
What is aging? What is its role in Alzheimer's disease? What can we do about it? J Alzheimers Dis (2005) 0.79
Estrogen replacement and risk of Alzheimer disease. JAMA (2003) 0.79
Hearing from parents: the impact of receiving the diagnosis of Williams syndrome in their child. Am J Med Genet A (2013) 0.79
Multigene interactions and the prediction of depression in the Wisconsin Longitudinal Study. BMJ Open (2012) 0.79
Predicting atrial fibrillation and flutter using electronic health records. Conf Proc IEEE Eng Med Biol Soc (2012) 0.78
Targeting gonadotropins: an alternative option for Alzheimer disease treatment. J Biomed Biotechnol (2006) 0.78
A human pluripotent stem cell platform for assessing developmental neural toxicity screening. Stem Cell Res Ther (2013) 0.78
Cone structure in subjects with known genetic relative risk for AMD. Optom Vis Sci (2014) 0.78
Beyond estrogen: targeting gonadotropin hormones in the treatment of Alzheimer's disease. Curr Drug Targets CNS Neurol Disord (2004) 0.78
Cerebral hemorrhage and amyloid-beta. Science (2003) 0.78
The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease. Drugs R D (2006) 0.78
Identification of a regulatory loop for the synthesis of neurosteroids: a steroidogenic acute regulatory protein-dependent mechanism involving hypothalamic-pituitary-gonadal axis receptors. J Neurochem (2009) 0.78